Roche, Jnana sign multi-target collaboration deal for small molecule drugs

Jnana Therapeutics has signed a multi-target collaboration and license deal worth over $1bn with Roche for the discovery of small molecule drugs for the treatment of immune-mediated and neurological diseases.